Assessing the Diagnostic Values of the Neutrophil-to-Lymphocyte Ratio (NLR) and Systematic Immunoinflammatory Index (SII) as Biomarkers in Predicting COVID-19 Severity: A Multicentre Comparative Study
Open Access
Abstract
COVID-19 has been notoriously unpredictable in its clinical course. Such unpredictability poses a challenge to clinicians in predicting patients who will develop severe cases and possibly die from the infection. This study aims to assess and compare the diagnostic value of the NLR and SII as biomarkers in predicting COVID-19 severity, represented by mortality, with a multicentre comparative study including 855 patients in Saudi Arabia. Descriptive and analytical statistics were used to compare haematological indices between survivors and non-survivors. The median age of patients included was 41 years old, with an almost equal ratio of men to women. Most participants were Saudis, and the mortality rate in the study cohort was 13.22%. Non-survivors, as compared to survivors, were significantly older, had lower RBC counts, haemoglobin and haematocrit levels, as well as significantly higher WBC and neutrophil counts. Both the NLR and SII were capable of differentiating between survivors and non-survivors, with the latter having significantly higher values. However, the NLR was superior to the SII in such differentiation, as it had a larger area under the curve. This study further confirms the diagnostic values of the NLR and SII as biomarkers in predicting COVID-19 severity and mortality, with the NLR being more sensitive and specific. Clinical guidelines on managing COVID-19 cases should benefit from these findings by harnessing the value of the NLR in COVID-19 management.Keywords
Funding Information
- King Salman Center for Disability Research (KSRG-2023-460)
This publication has 45 references indexed in Scilit:
- Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopeniaImmunity, Inflammation and Disease, 2023
- Hemolytic anemia in COVID-19Annals of Hematology, 2022
- On-admission anemia predicts mortality in COVID-19 patients: A single center, retrospective cohort studyThe American Journal of Emergency Medicine, 2021
- Autoimmunity roots of the thrombotic events after COVID-19 vaccinationAutoimmunity Reviews, 2021
- COVID-19 and the kidney: time to take a closer lookInternational Urology and Nephrology, 2021
- Adaptive immunity to SARS-CoV-2 and COVID-19Cell, 2021
- Anemia in patients with Covid-19: pathogenesis and clinical significanceClinical and Experimental Medicine, 2021
- Aging in COVID-19: Vulnerability, immunity and interventionAgeing Research Reviews, 2021
- Changes of hematological and immunological parameters in COVID-19 patientsInternational Journal of Hematology, 2020
- Mechanism of thrombocytopenia in COVID-19 patientsAnnals of Hematology, 2020